| Bezeichnung (EINECS und / oder andere) |
EC- Nummer |
CAS- Nummer |
PT01 |
PT02 |
PT03 |
PT04 |
PT05 |
PT06 |
PT07 |
PT08 |
PT09 |
PT10 |
PT11 |
PT12 |
PT13 |
PT14 |
PT15 |
PT16 |
PT17 |
PT18 |
PT19 |
PT20 |
PT21 |
PT22 |
PT23 |
| Dimethyltetradecyl[3-(trimetho- xysilyl) propyl] ammoniumchlorid |
255-451-8 |
41591-87-1 |
|
|
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gemisch aus cis- und trans-p- Menthan-3,8 diol / Citriodiol |
255-953-7 |
42822-86-6 |
1 |
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
|
| 4,4-Dimethyloxazolidin |
257-048-2 |
51200-87-4 |
|
|
|
|
|
6 |
|
|
|
|
11 |
12 |
13 |
|
|
|
|
|
|
|
|
|
|
| Ethyl-N-acetyl-N-butyl-.beta.-alaninat |
257-835-0 |
52304-36-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
|
| .alpha.-Cyan-3- phenoxybenzyl 3- (2,2-dichlorvinyl)-2,2- dimethylcyclo- propancarboxylat / Cypermethrin |
257-842-9 |
52315-07-8 |
|
|
|
|
|
|
|
8 |
9 |
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| m-Phenoxybenzyl 3-(2,2-dichlor- vinyl)-2,2-dimethylcyclopropan- carboxylat / Permethrin |
258-067-9 |
52645-53-1 |
|
2 |
3 |
|
5 |
|
|
8 |
9 |
|
|
|
|
|
|
|
|
18 |
19 |
|
|
22 |
|
| .alpha.-Cyan-3-phenoxybenzyl- [1R-[1.alpha. (S*),3.alpha.]] 3-(2,2-dibromvinyl) -2,2- dimethyl cyclopropan- carboxylat/Deltamethrin |
258-256-6 |
52918-63-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 1-Ethinyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl) cyclopropancarboxylat/Empenthrin |
259-154-4 |
54406-48-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 3-Iod-2-propinyl-butylcarbamat |
259-627-5 |
55406-53-6 |
|
|
|
|
|
6 |
7 |
8 |
9 |
10 |
11 |
|
13 |
|
|
|
|
18 |
|
|
|
|
|
| Tetrakis(hydroxymethyl) phosphoniumsulfat (2: 1) |
259-709-0 |
55566-30-8 |
|
2 |
|
|
|
6 |
|
|
9 |
|
11 |
12 |
|
|
|
|
|
|
|
|
|
|
|
| 3-(3-Biphenyl-4-yl-1,2,3,4-tetra- hydro-1-naphthyl)-4- hydroxycumarin/Difenacoum |
259-978-4 |
56073-07-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
|
|
|
|
|
|
| 4-Hydroxy-3-(3-(4'-brom-4- biphenylyl)-1,2,3,4-tetrahydro- 1-naphthyl) cumarin/Brodifacoum |
259-980-5 |
56073-10-0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
|
|
|
|
|
|
| 1-[[2-(2,4-Dichlorphenyl)-4-pro- pyl-1,3-dioxolan-2-yl]methyl]- 1H-1,2,4-triazol/Propiconazol |
262-104-4 |
60207-90-1 |
1 |
2 |
|
4 |
|
|
7 |
8 |
9 |
10 |
|
12 |
13 |
|
|
|
|
|
|
20 |
|
|
|
| 4,5-Dichlor-2-octyl- 2H-isothiazol-3-on |
264-843-8 |
64.359-81-5 |
|
|
|
|
|
6 |
7 |
8 |
9 |
10 |
11 |
12 |
|
|
|
|
|
|
|
|
21 |
|
|
| 2-Chlor-N-[[[4-(trifluormethoxy)- phenyl]amino] carbonyl]benzamid |
264-980-3 |
64628-44-0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 3,3'-Methylen-bis[5-methyloxa- zolidin]/Oxazolidin |
266-235-8 |
66204-44-2 |
|
2 |
|
|
|
6 |
|
|
|
10 |
11 |
12 |
13 |
|
|
|
|
|
|
|
|
|
|
| N-Cyclopropyl-1,3,5-triazin- 2,4,6-triamin |
266-257-8 |
66215-27-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| cis-4-[3-(p-tert-Butylphenyl)-2- methylpropyl]-2,6-dimethyl- morpholin |
266-719-9 |
67564-91-4 |
|
|
|
|
|
6 |
7 |
8 |
9 |
10 |
|
12 |
13 |
|
|
|
|
|
|
|
21 |
|
|
| .alpha.-Cyan-4-fluor-3-phenoxy- benzyl 3-(2,2-dichlorvinyl)-2,2- dimethyl- cyclopropan- carboxylat/Cyfluthrin |
269-855-7 |
68359-37-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
..
| Bezeichnung (EINECS und / oder andere) |
EC- Nummer |
CAS- Nummer |
PT01 |
PT02 |
PT03 |
PT04 |
PT05 |
PT06 |
PT07 |
PT08 |
PT09 |
PT10 |
PT11 |
PT12 |
PT13 |
PT14 |
PT15 |
PT16 |
PT17 |
PT18 |
PT19 |
PT20 |
PT21 |
PT22 |
PT23 |
| Quaternäre Ammoniumverbindungen, Benzyl-C12-18-alkyldimethyl-, Chloride |
269-919-4 |
68391-01-5 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
|
9 |
10 |
11 |
12 |
13 |
|
|
16 |
17 |
18 |
19 |
|
21 |
22 |
|
| Quaternäre Ammoniumverbindungen, Benzyl-C12-16-alkyldimethyl-, Chloride |
270-325-2 |
68.424-85-1 |
1 |
2 |
3 |
4 |
|
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
|
|
|
|
|
|
|
|
|
|
| Quaternäre Ammoniumverbindungen, Di-C8-10-alkyldimethyl, Chloride |
270-331-5 |
68424-95-3 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
|
9 |
10 |
11 |
12 |
13 |
|
|
16 |
|
|
|
|
|
22 |
|
| Fettsäuren, Kokos-, Reaktions- produkte mit Diethanolamin |
270-430-3 |
68440-04-0 |
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quaternäre Ammoniumverbindungen, Benzyl-C12-18-alkyldimethyl-, Salze mit 1,2- Benzisothiazol-3(2H)-on-1,1-dioxid (1: 1) |
273-545-7 |
68989-01-5 |
|
2 |
|
4 |
|
|
|
|
|
|
11 |
12 |
|
|
|
|
|
|
|
|
|
|
|
| Natrium-N-(hydroxymethyl) glycinat |
274-357-8 |
70161-44-3 |
|
|
|
|
|
6 |
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amine, C10-16-Alkyldimethyl-, N-Oxide |
274-687-2 |
70592-80-2 |
1 |
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pentakalium- bis(peroxymonosulfat)bis (sulfat) |
274-778-7 |
70693-62-8 |
1 |
2 |
3 |
4 |
5 |
|
|
|
|
|
11 |
12 |
|
|
|
|
|
|
|
|
|
|
|
| N, N'-(Decan-1,10-diyldi-1(4H)- pyridyl-4-yliden)bis (octylammonium) dichlorid |
274-861-8 |
70775-75-6 |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,3-Didecyl-2-methyl-1H- imidazoliumchlorid |
274-948-0 |
70862-65-6 |
|
2 |
3 |
4 |
|
6 |
7 |
|
|
10 |
11 |
12 |
13 |
|
|
|
|
|
|
|
|
|
|
| 1-[1,3-Bis(hydroxymethyl)-2,5- dioxoimidazolidin-4-yl]-1,3-bis (hydroxymethyl) harnstoff / Diazolidinylurea |
278-928-2 |
78491-02-8 |
|
|
|
|
|
6 |
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Magnesiummonoperoxyphthalat Hexahydrat |
279-013-0 |
84665-66-7 |
|
2 |
3 |
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tributyltetradecyl- phosphoniumchlorid |
279-808-2 |
81741-28-8 |
|
2 |
|
4 |
|
|
|
|
9 |
|
11 |
12 |
|
|
|
|
|
|
|
|
|
|
|
| Margosa, Extrakt |
283-644-7 |
84696-25-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
19 |
|
|
|
|
| Teersäuren, Polyalkylphenol- Fraktion |
284-893-4 |
84989-05-9 |
|
2 |
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Melaleuca alternifolia, Extrakt / Australisches Teebaumöl |
285-377-1 |
85085-48-9 |
1 |
2 |
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
|
..
| Bezeichnung (EINECS und / oder andere) |
EC- Nummer |
CAS- Nummer |
PT01 |
PT02 |
PT03 |
PT04 |
PT05 |
PT06 |
PT07 |
PT08 |
PT09 |
PT10 |
PT11 |
PT12 |
PT13 |
PT14 |
PT15 |
PT16 |
PT17 |
PT18 |
PT19 |
PT20 |
PT21 |
PT22 |
PT23 |
| 2,4,8,10-Tetra(tert-butyl) -6- hydroxy- 12H-dibenzo[d, g][1,3,2] dioxaphosphocin-6- oxid, Natriumsalz |
286-344-4 |
85209-91-2 |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quaternäre Ammoniumverbindungen, Benzyl-C12-14-alkyldi methyl-, Chloride |
287-089-1 |
85409-22-9 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
|
9 |
10 |
11 |
12 |
13 |
|
|
16 |
17 |
18 |
19 |
|
21 |
22 |
|
| Quaternäre Ammoniumverbindungen, C12-14-Alkyl[(ethylphenyl) methyl]dimethyl-, Chloride |
287-090-7 |
85409-23-0 |
1 |
2 |
3 |
4 |
5 |
6 |
|
|
9 |
|
11 |
12 |
13 |
|
|
16 |
17 |
18 |
19 |
|
21 |
22 |
|
| .alpha.-Cyan-4-fluor-3- phenoxy- benzyl [1.alpha.(S*),3.alpha.] (±) 3-(2,2-dichlorvinyl) -2,2-dimethyl- cyclopropancarboxylat |
289-244-9 |
86560-93-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| Chrysanthemum cinerariaefolium, Extrakt |
289-699-3 |
89997-63-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
19 |
|
|
|
|
| Harnstoff, N,N'-Bis (hydroxymethyl)-, Reaktionsprodukte mit 2-(2-Butoxyethoxy) ethanol, Ethylenglykol und Formaldehyd |
292-348-7 |
90604-54-9 |
|
2 |
|
|
|
6 |
|
|
|
|
11 |
12 |
13 |
|
|
|
|
|
|
|
|
|
|
| Wacholder, Juniperus mexicana, Extrakt |
294-461-7 |
91722-61-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
|
| Lavendel, Lavandula hybrida, Extrakt / Lavandinöl |
294-470-6 |
91722-69-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
19 |
|
|
|
|
| Kiefern, Extrakt |
304-455-9 |
94266-48-5 |
|
|
|
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quaternäre Ammoniumverbindungen, [2-[[2-[(2-Carboxyethyl) (2-hydroxyethyl) amino] ethyl]amino]-2- oxoethyl]- kokosalkyl dimethyl-, Hydroxide, Innere Salze |
309-206-8 |
100085-64-1 |
1 |
2 |
3 |
4 |
|
6 |
7 |
|
|
10 |
11 |
12 |
13 |
|
|
|
|
|
|
|
|
|
|
| Maiskolben, pulverisiert |
310-127-6 |
999999-99-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
|
|
|
|
|
|
| 1-(3,5-Dichlor-4-(1,1,2,2-tetra- fluorethoxy)phenyl)-3-(2,6- difluorbenzoyl) harnstoff / Hexaflumuron |
401-400-1 |
86479-06-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 1,3-Dichlor-5-ethyl-5- methylimidazolidin- 2,4-dion |
401-570-7 |
89415-87-2 |
|
2 |
|
|
|
|
|
|
|
|
11 |
12 |
|
|
|
|
|
|
|
|
|
|
|
..
| Bezeichnung (EINECS und / oder andere) |
EC- Nummer |
CAS- Nummer |
PT01 |
PT02 |
PT03 |
PT04 |
PT05 |
PT06 |
PT07 |
PT08 |
PT09 |
PT10 |
PT11 |
PT12 |
PT13 |
PT14 |
PT15 |
PT16 |
PT17 |
PT18 |
PT19 |
PT20 |
PT21 |
PT22 |
PT23 |
| 1-(4-Chlorphenyl)-4,4-dimethyl- 3-(1,2,4-triazol-1-ylmethyl) pen- tan-3-ol / Tebuconazol |
403-640-2 |
107534-96-3 |
|
|
|
|
|
|
7 |
8 |
9 |
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reaktionsprodukte aus: Glutaminsäure und N-(C12-14-alkyl)propylendiamin |
403-950-8 |
164.907-72-6 |
1 |
2 |
3 |
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gemisch aus: (C8-18)Alkylbis(2-hydroxyethyl) ammoniumbis(2-ethylhexyl)phosphat; (C8-18)Alkylbis(2-hydroxyethyl) ammonium-2-ethylhexylhydrogenphosphat |
404-690-8 |
68.132-19-4 |
|
|
|
|
|
6 |
7 |
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2,3,5,6-Tetrafluorbenzyl-trans-2- (2,2-dichlorvinyl) -3,3-dimethyl cyclopropancarboxylat / Transfluthrin |
405-060-5 |
118712-89-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 5,5- Dimethylperhydro- pyrimidin-2-on-.alpha.- (4-trifluor- methylstyryl)-.alpha.-(4-trifluormethyl) cinnamylidenhydrazon / Hydramethylnon |
405-090-9 |
67485-29-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 3-Phenoxybenzyl-2-(4-ethoxy- phenyl) -2-methylpropylether / Etofenprox |
407-980-2 |
80844-07-1 |
|
2 |
3 |
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 6-(Phthalimid) peroxyhexansäure |
410-850-8 |
128275-31-0 |
1 |
2 |
3 |
4 |
|
|
|
|
|
|
11 |
12 |
|
|
|
|
|
|
|
|
|
|
|
| Methylneodecanamid |
414-460-9 |
105726-67-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
|
|
|
| Gemisch aus: .alpha.-Cyan-3-phenoxybenzyl -(Z)-(1R,3R)-[(S) 3-(2-chlor-3,3,3-trifluorprop-1- enyl)] -2,2-dimethylcyclo- propancarboxylat; .alpha.-Cyan-3- phenoxybenzyl- (Z)-(1S,3S)-[(R)-3- (2-chlor-3,3,3-trifluorprop-1-enyl)] 2,2-dimethyl- cyclopropan- carboxylat/Lambda Cyhalothrin |
415-130-7 |
91465-08-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
| 1-(4-(2-Chlor-.alpha., alpha.,.alpha. -p-trifluortolyloxy)-2- fluorphenyl)-3- (2,6-difluorben- zolyl)harnstoff / Flufenoxuron |
417-680-3 |
101463-69-8 |
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
